Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors

Vox Sanguinis

Volumn 107, Issue 3, 2014, Pages 226-232

  Juhl, D ^a   Gorg S ^a   Hennig, H ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

B19V; Blood donors; Parvovirus b19 infection; Transfusion transmitted infections

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; NEUTRALIZING ANTIBODY; PROTEIN VP1; VIRUS DNA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ANTIBODY TITER; ARTICLE; BLOOD COMPONENT; BLOOD DONOR; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA INFECTIOSUM; FEMALE; HUMAN; HUMAN PARVOVIRUS B19; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; VIREMIA; VIRUS DETECTION; WESTERN BLOTTING; ADOLESCENT; ADULT; BLOOD; CHILD; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; PARVOVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; TRANSMISSION; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; BLOOD DONORS; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84925340137     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12162     Document Type: Article

References (31)

1. Young NS, Brown KE: Parvovirus B19. N Engl J Med 2004; 350:586-597
2. Blümel J, Burger R, Drosten C, et al.: Parvovirus B19 - Revised. Transfus Med Hemother 2010; 37:339-350
3. Brown KE, Anderson SM, Young NS: Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993; 262:114-117
4. Plentz A, Würdinger M, Kudlich M, et al.: Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia. J Clin Virol 2013; 58:443-448
5. Juhl D, Steppat D, Görg S, et al.: Parvovirus B 19 (B19V) infections and blood counts in blood donors. Transfus Med Hemother 2014; 41:52-59
6. Röhrer C, Gärtner B, Sauerbrei A, et al.: Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect 2008; 136:1564-1575
7. Schmidt M, Themann A, Drexler C, et al.: Blood donor screening for parvovirus B19 in Germany and Austria. Transfusion 2007; 47:1775-1782
8. Lefrère JJ, Servant-Delmas A, Candotti D, et al.: Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood 2005; 106:2890-2895
9. Matsukura H, Shibata S, Tani Y, et al.: Persistent infection by human parvovirus B19 in qualified blood donors. Transfusion 2008; 48:1036-1037
10. Parsyan A, Candotti D: Human erythrovirus B19 and blood transfusion - an update. Transfus Med 2007; 17:263-278
11. Kleinman SH, Glynn SA, Lee TH, et al.: A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion. Blood 2009; 114:3677-3683
12. Satake M, Hoshi Y, Taira R, et al.: Symptomatic parvovirus B19 infection caused by blood component transfusion. Transfusion 2011; 51:1887-1895
13. Hourfar MK, Mayr-Wohlfart U, Themann A, et al.: Recipients potentially infected with parvovirus B19 by red blood cell products. Transfusion 2011; 51:129-136
14. Tsukada Y, Yokoyama K, Ishida A, et al.: Erythroid crisis caused by parvovirus B19 transmitted via red blood cell transfusion. Intern Med 2011; 50:2379-2382
15. Brown KE, Young NS, Alving BM, et al.: Parvovirus B19: implications for transfusion medicine. Summary of a workshop. Transfusion 2001; 41:130-135
16. Thomas I, Di Giambattista M, Gérard C, et al.: Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins. Vox Sang 2003; 84:300-307
17. Kleinman SH, Glynn SA, Lee TH, et al.: Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion 2007; 47:1756-1764
18. Koppelman MH, Cuijpers HT, Wessberg S, et al.: Multicenter evaluation of a commercial multiplex polymerase chain reaction test for screening plasma donations for parvovirus B19 DNA and hepatitis A virus RNA. Transfusion 2012; 52:1498-1508
19. Müller MM, Fraile MI, Hourfar MK, et al.: Evaluation of two, commercial, multi-dye, nucleic acid amplification technology tests, for HBV/HCV/HIV-1/HIV-2 and B19V/HAV, for screening blood and plasma for further manufacture. Vox Sang 2013; 104:19-29
20. Lee TH, Kleinman SH, Wen L, et al.: Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donors. Transfusion 2011; 51:1896-1908
21. Dodd RY: B19: benign or not? Transfusion 2011; 51:1878-1879
22. Eis-Hübinger AM, Reber U, Abdul-Nour T, et al.: Evidence for persistence of parvovirus B19 DNA in livers of adults. J Med Virol 2001; 65:395-401
23. Norja P, Hokynar K, Aaltonen LM, et al.: Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A 2006; 103:7450-7453
24. Kuethe F, Lindner J, Matschke K, et al.: Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Clin Infect Dis 2009; 49:1660-1666
25. Doyle S, Corcoran A: The immune response to parvovirus B19 exposure in previously seronegative and seropositive individuals. J Infect Dis 2006; 194:154-158
26. Food and Drug Administration: Nucleic Acid Testing (NAT) to Reduce the Possible Risk of Human Parvovirus B19 Transmission by Plasma-Derived Products. Available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm078510.pdf [last accessed 27 May 2014].
27. Daly P, Corcoran A, Mahon BP, et al.: High-sensitivity PCR detection of parvovirus B19 in plasma. J Clin Microbiol 2002; 40:1958-1962
28. Bansal GP, Hatfield JA, Dunn FE, et al.: Candidate recombinant vaccine for human B19 parvovirus. J Infect Dis 1993; 167:1034-1044
29. Saikawa T, Anderson S, Momoeda M, et al.: Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol 1993; 67:3004-3009
30. Yu MY, Alter HJ, Virata-Theimer ML, et al.: Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples. Transfusion 2010; 50:1712-1721
31. Groeneveld K, van der Noordaa J: Blood products and parvovirus B19. Neth J Med 2003; 61:154-156